Preview

Pfizer's Lipitor New Strategy for Patent Expired

Powerful Essays
Open Document
Open Document
1877 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Pfizer's Lipitor New Strategy for Patent Expired
[pic]
行銷管理與顧客分析
2012/1/31

Pfizer’s Lipitor new strategy for patent expired

NTU EMBA 100B
Paul, Wai-Hou Chan
陳惠濠

Table of Contents

I. Introduction

II. About Lipitor (Atorvastatin)

III. Pfizer’s strategy

IV. Patients seem to benefit from Pfizer’s new strategy

V. Potentially profitable for retailers

VI. Pfizer after Lipitor

VII. Is Pfizer’s Lipitor strategy working?

VIII. Wholesaler Profits: Brand vs. Generic drug

IX. Pfizer is hoping to sell Lipitor to consumers over the counter (OTC)

X. Discussion

XI. References

Introduction

Lipitor (Atorvastatin), the best-selling prescription medication in the United States in

2010, earned more than $7 billion in total revenue. Lipitor’s patent expired in June

2011. Lipitor came on the market in 1997. According to CNBC (Consumer News and

Business Channel), it has yielded nearly $100 billion for Pfizer which represents

about a quarter of Pfizer’s total revenue over the past decade. When a drug’s patent

expires, the first generic company to file is usually granted a six-month period of

exclusivity to offer the generic version of the drug. Following the initial six-month

exclusivity period, additional generics companies are allowed to offer the drug and

the market quickly becomes commoditized. Typically, the exclusivity period results in

prices 25% below the original brand price, followed by continued price erosion to as

much as 80% or more as multiple generics enter the market. In the past, upon patent

expiration, the original drug maker would often raise the price of the brand to offset

some of the volume decline and usually shift commercial focus to its newer products.

Ultimately the brand would retain less than 10 percent of the market share by volume

(usually 3-5% after a few years). However, Pfizer has implemented a new, aggressive

post-patent strategy to maintain as much of the Lipitor market



References: 1. Cynthia A. Jackevicius, Pharm.D., Mindy M. Chou, Pharm.D., Joseph S. Ross, M.D., M.H.S., Nilay D. Shah, Ph.D., and Harlan M. Krumholz, M.D. January 19, 2012, Generic Atorvastatin and Health Care Costs, N Engl J Med 2012; 366:201-204 2. Niteesh K. Choudhry, M.D., Ph.D., and William H. Shrank, M.D., M.S.H.S. November 11, 2010, Four-Dollar Generics — Increased Accessibility, Impaired Quality Assurance, N Engl J Med 2010; 363:1885-1887 3. Michael O 'Riordan, August 4, 2011, Pfizer wants atorvastatin available over the counter: Wall Street Journal Available at: http://theheart.org 4. Pfizer’s Lipitor Strategy Changes the Generics Game, Posted on November 30, 2011, Available at: http://bournepartners.wordpress.com 5. Philip Kotler, Kevin Lane Keller, Swee Hoon Ang, Siew Meng Leong, Chin Tiong Tan,(2009). Marketing Management An Asian Perspective (5th ed.) Singapore: Pearson Education

You May Also Find These Documents Helpful

  • Powerful Essays

    Persuasive Speech Outline

    • 1329 Words
    • 6 Pages

    IV. (Preview) Today, I want to talk about generic drugs. I want to talk why they are equal to brand name drugs, why they are cheaper than brand name drugs, the different inactive ingredients in both generic and brand name drugs. I want to basically persuade all of you that it is more than okay to take generic drugs, whether they be prescription or over the counter.…

    • 1329 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    Connelly, J. (2003, March 18). Prescription drugs: A guide to options that can cut costs. Retrieved March 22, 2004, from Opposing Viewpoints Resource Center database.…

    • 3401 Words
    • 14 Pages
    Powerful Essays
  • Good Essays

    Some medicines are beyond the scope of the FDA regulatory authority or some are approved to be used in other ways. Often some problems occur after the product has been approved by the FDA (Hooper, 2008). A manufacturer of the popular cholesterol reducing drug recalled 40 batches after finding out that it may contain small particles of glass. The glass particles were similar to the size of a grain of sand. If ingested it could be dangerous. There were no true adverse effects related to the recall are very low which means there are no injuries reported The pharmaceutical company Ranbaxy is recalling bottles of 10, 20, and 40 milligram tablets atorvastatin calcium, the generic version of Lipitor. The FDA granted the company approval of the manufacture of drug in New Jersey in 2011. Ranbaxy has been under the radar since 2006 for submitting false data to FDA and barred the company from manufacturing drugs in the United States until they met standards. Patients needed to find out if they pills they are taking are in the recall. All pharmacies recommend patients to check and see if their medicine is included in the recall before they take another dosage of their medicine. The patients do not have to do much as far as insurance purposes because they are automatically notified. If patient receives their medicine from the pharmacy they can swap out their pills there and mail order patients will…

    • 736 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    Most companies don’t compete directly on price for new drugs. This is usually done through the insurance companies…

    • 1517 Words
    • 7 Pages
    Powerful Essays
  • Powerful Essays

    Prescription drugs whose patents have expired are highly elastic; however, prescription drugs whose patents still exist are highly inelastic. Many consumers will substitute generic brands for drugs that have had their patents expire. These generic drugs can be produced at a much lower cost and yet still contain the active ingredients and FDA approval to their brand name equivalent. As a result, supply increases along with demand and puts downward pressure on price. Because there are no substitutes for patented drugs, consumers have no choice but to pay the higher prices determined by supply and demand…

    • 1538 Words
    • 7 Pages
    Powerful Essays
  • Powerful Essays

    Provider Consolidation Paper

    • 3976 Words
    • 16 Pages

    Figure SEQ Figure \* ARABIC 5 Analysis of Price Sensitivities by Disease and Product Characteristics. These can be used to design endpoints in clinical trials…

    • 3976 Words
    • 16 Pages
    Powerful Essays
  • Satisfactory Essays

    Langreth, R. (2014, May). Big pharma 's favorite prescription: higher prices. , (), . Retrieved from…

    • 575 Words
    • 3 Pages
    Satisfactory Essays
  • Powerful Essays

    Strategy: Pfizer is the world’s number one pharmaceutical company. Its best-selling products include Lipitor, the world’s best- selling medicine, and eight of the top twenty-five medicines in the world. Acquisition of successful competitors such as Pharmacia and Warner Lambert has helped Pfizer to offer best-selling products and further differentiate itself from competitors. The acquisition of the latter company helped bring Lipitor under Pfizer’s control.…

    • 3675 Words
    • 15 Pages
    Powerful Essays
  • Powerful Essays

    Pricing medication is dependent on which pharmaceutical company manufactured the drug. A patent gives a drug company monopoly power, and they can set the price above marginal cost (P>MC). The price is higher so the company can reap the profits. Although there is no chemical difference between the generic equivalent of a name brand drug, consumers may continue to purchase the name brand drug because they are familiar with the name. Once other drug companies start manufacturing, the price of the drug will drop.…

    • 1191 Words
    • 5 Pages
    Powerful Essays
  • Powerful Essays

    The competitive elements currently operating in the U.S. healthcare system are the character of the constantly transforming industry. The increase of the pace of competition within the healthcare system takes place among different organizations. This paper will describe the different forms of that competition among organizations, explain the benefits and the downfalls of competition, offer an alternative if competition was not the main force behind the U.S. healthcare system, define elements of successful competition, explain how competitive intelligence is used, illustrate how competition influences both the services offered by healthcare organizations and the choices patients have.…

    • 1291 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    The effects of an AOR (action-observation-reflection) based Supplier Monitoring Program on the Quality of Strategic Supplier Performance.…

    • 28738 Words
    • 115 Pages
    Powerful Essays
  • Good Essays

    According to Ventola (2011), the drug shortages have an influenced on healthcare in the forthcoming. Institute for Safe Medication Practices conducted a survey in 2010, of healthcare workers to determine the unavailability of drugs. The survey revealed that 84% reported the FDA nor the manufacturers provided a warning, 78% stated the price to comparable drugs were expensive, 70% stated no available options, and 64% also reported that unavailability of drugs caused a risk of undesirable patient outcomes (Ventola, 2011).…

    • 79 Words
    • 1 Page
    Good Essays
  • Better Essays

    Merck & Co

    • 1066 Words
    • 5 Pages

    1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop a new drug?…

    • 1066 Words
    • 5 Pages
    Better Essays
  • Better Essays

    Mapping Innovation

    • 1514 Words
    • 7 Pages

    Research and markets. (2011, September). United States Pharmaceuticals and Healthcare Report Q4 2011. Retrieved from http://www.researchandmarkets.com/research/b8d7a0/united_states_phar…

    • 1514 Words
    • 7 Pages
    Better Essays
  • Powerful Essays

    Sanofi-Aventis Acquisition

    • 5913 Words
    • 19 Pages

    With regards to the market share ranking of the pharmaceutical sector by revenues, the leader in 2003 was Pfizer, GlaxoSmithKline, Merck, Johnson & Johnson and Aventis. However, due to patent expirations and new successful drug launches, the ranking of top pharmaceutical companies constantly faces numerous variations. The most sold drug in 2003 was Lipitor manufactured by Pfizer, with a global market share of 2.2%, or equivalently sales worth $10.3 billion. During this time, there were 64 blockbusters (products generating over $ 1 billion in sales).…

    • 5913 Words
    • 19 Pages
    Powerful Essays